BACKGROUND:Patients with head and neck cancer experience significant weight loss secondary to concurrent chemoradiotherapy (CCRT). Using dual-energy X-ray absorptiometry (DEXA) scans, we characterize total body composition changes during and after CCRT in order to develop novel clinical care models that will improve the patient's quality of life (QOL). METHODS: Sixty DEXA scans were obtained from 12 patients undergoing CCRT for locally advanced squamous cell head and neck cancer. DEXAs were performed at baseline, during treatment, completion of CCRT, and then 1 and 2 months posttreatment. RESULTS:Mean weight loss by treatment end was 9.5 kg (10.2%; p = .0002). On average, lean body mass (LBM) decreased 10.2% (p = .001), and fat body mass (FBM) decreased 11.1% (p = .001) during CCRT. LBM began to normalize after completion of treatment, whereas FBM continued to decline. CONCLUSION: Substantial loss of muscle and FBM occurs in patients undergoing CCRT for head and neck cancer. To prevent long-term disability and QOL decline after curative CCRT, clinical care interventions incorporating aggressive nutrition/exercise counseling are needed.
RCT Entities:
BACKGROUND:Patients with head and neck cancer experience significant weight loss secondary to concurrent chemoradiotherapy (CCRT). Using dual-energy X-ray absorptiometry (DEXA) scans, we characterize total body composition changes during and after CCRT in order to develop novel clinical care models that will improve the patient's quality of life (QOL). METHODS: Sixty DEXA scans were obtained from 12 patients undergoing CCRT for locally advanced squamous cell head and neck cancer. DEXAs were performed at baseline, during treatment, completion of CCRT, and then 1 and 2 months posttreatment. RESULTS: Mean weight loss by treatment end was 9.5 kg (10.2%; p = .0002). On average, lean body mass (LBM) decreased 10.2% (p = .001), and fat body mass (FBM) decreased 11.1% (p = .001) during CCRT. LBM began to normalize after completion of treatment, whereas FBM continued to decline. CONCLUSION: Substantial loss of muscle and FBM occurs in patients undergoing CCRT for head and neck cancer. To prevent long-term disability and QOL decline after curative CCRT, clinical care interventions incorporating aggressive nutrition/exercise counseling are needed.
Authors: Joanne S Hiatt; Adrienne Young; Teresa E Brown; Merrilyn Banks; Judith Bauer Journal: Support Care Cancer Date: 2021-08-14 Impact factor: 3.603
Authors: Shuang G Zhao; Neil B Alexander; Zora Djuric; Jessica Zhou; Yebin Tao; Matthew Schipper; Felix Y Feng; Avraham Eisbruch; Francis P Worden; Scott J Strath; Shruti Jolly Journal: Head Neck Date: 2015-10-07 Impact factor: 3.147
Authors: Aaron J Grossberg; Sasikarn Chamchod; Clifton D Fuller; Abdallah S R Mohamed; Jolien Heukelom; Hillary Eichelberger; Michael E Kantor; Katherine A Hutcheson; G Brandon Gunn; Adam S Garden; Steven Frank; Jack Phan; Beth Beadle; Heath D Skinner; William H Morrison; David I Rosenthal Journal: JAMA Oncol Date: 2016-06-01 Impact factor: 31.777
Authors: Chen Wang; Jeffrey M Vainshtein; Maria Veksler; Patrick E Rabban; June A Sullivan; Stewart C Wang; Avraham Eisbruch; Shruti Jolly Journal: Springerplus Date: 2016-04-11
Authors: Camilla K Lonkvist; Simon Lønbro; Anders Vinther; Bo Zerahn; Eva Rosenbom; Hanne Primdahl; Pernille Hojman; Julie Gehl Journal: BMC Cancer Date: 2017-06-03 Impact factor: 4.430
Authors: Peter Soldos; Zsuzsanna Besenyi; Katalin Hideghéty; László Pávics; Ádám Hegedűs; Levente Rácz; Bence Kopper Journal: Pathol Oncol Res Date: 2021-06-29 Impact factor: 3.201
Authors: Zi Zhang; Justin C Brown; Bert W O'Malley; Andrea B Troxel; Joshua M Bauml; Kaitlyn R Rubnitz; Colleen M Grosso; Gregory S Weinstein; Kathryn H Schmitz Journal: Support Care Cancer Date: 2015-12-01 Impact factor: 3.359